FOI release

FOI2022/00107: Membership of all UK CTAP subgroup panels/conflicts of interest

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2022/00107

Published 14 April 2022

Request

Request Received: 21 March 2022

Throughout 2021, UK-CTAP were investigating drug candidates for COVID-19. To my knowledge, there has never been full disclosure of who sat on each subgroup panel. We have only the chairs for each panel. The process aimed to be transparent but we only have limited notes on how decisions were reached, never who formulated those decisions.

A recent document, "Therapeutics Advisory Panel for Pandemic Operating Model", suggests on page 3 that panel members should have 'no vested interests' but notes 'there will at times be conflicts of interest that will need to be managed. It is important to surface these conflicts of interest and manage them appropriately'

As such, please provide a full list of the CTAP panel membership throughout the 2021 decision-making process. Please include a full breakdown of membership, including who sat on the subgroup panels. Also please provide any conflicts of interest assessments that were surfaced and properly managed at the time.

Response

Response Sent: 14 April 2022

Full details of this response are provided in the attached document.

Documents

• FOI_Response_Letter_FOI2022_00107_Redacted.pdf (233.4 KB)

This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.